{"ticker": {"uuid": "8fde5292-4d73-47b7-9fe3-8c3824300c46", "symbol": "CELZ", "name": "Creative Medical Technology Holdings Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Creative Medical Technology (CELZ) plans big share boost and warrant approval", "summary": "Creative Medical Technology Holdings, Inc. (CELZ) is calling a special stockholder meeting on August 28, 2026, to vote on two key proposals. These include increasing authorized common stock from 25 million to 100 million shares and approving the full exercise of private-placement", "url": "https://www.stocktitan.net/sec-filings/CELZ/def-14a-creative-medical-technology-holdings-inc-definitive-proxy-sta-da99175a72f4.html", "source_name": "Stock Titan", "published_at": "2026-07-14T19:49:48", "published_display": "14 Jul 2026 19:49", "sentiment": "negative", "sentiment_pct": 40, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Creative Medical Technology enters into agreement with existing warrant holders", "summary": "Creative Medical Technology Holdings, Inc. entered into inducement agreements with existing warrant holders, lowering the exercise price from $2.86 to $1.60 per share, which led to the exercise of warrants covering 2,790,340 common shares and raised approximately $4.5 million. Th", "url": "https://medicalbuyer.co.in/creative-medical-technology-enters-into-agreement-with-existing-warrant-holders/", "source_name": "Medical Buyer", "published_at": "2026-07-06T08:12:11", "published_display": "06 Jul 2026 08:12", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical Technology Raises $4.5M From Warrant Exercises, Reprices and Issues New 5-Year Warrants", "summary": "Creative Medical Technology (CELZ) has reportedly raised approximately $4.5 million in gross proceeds through warrant exercise inducement letters with existing warrant holders. The company reduced the exercise price from $2.86 to $1.60 per share, and in return, will issue new ind", "url": "https://www.tradingview.com/news/tradingview:c96d2de670ac5:0-creative-medical-technology-raises-4-5m-from-warrant-exercises-reprices-and-issues-new-5-year-warrants/", "source_name": "TradingView", "published_at": "2026-07-03T11:10:00", "published_display": "03 Jul 2026 11:10", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical Technology awards $100,000 bonus to CEO Timothy Warbington", "summary": "Creative Medical Technology Holdings (CELZ) has awarded its CEO, Timothy Warbington, a bonus of $100,000. The bonus was approved by the board's Compensation Committee and became effective on July 1, 2026. The information was sourced from an SEC 8-K filing.", "url": "https://www.tradingview.com/news/tradingview:e88da564db662:0-creative-medical-technology-awards-100-000-bonus-to-ceo-timothy-warbington/", "source_name": "TradingView", "published_at": "2026-07-02T20:39:21", "published_display": "02 Jul 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical (CELZ) secures $4.5M and issues 5.58M inducement warrants", "summary": "Creative Medical Technology Holdings (CELZ) has secured approximately $4.5 million in gross proceeds through an inducement offer, encouraging warrant holders to exercise 2,790,340 existing warrants at a reduced price of $1.60 per share. In exchange, the company issued 5,580,680 n", "url": "https://www.stocktitan.net/sec-filings/CELZ/8-k-creative-medical-technology-holdings-inc-reports-material-event-3937323446b5.html", "source_name": "Stock Titan", "published_at": "2026-07-02T20:39:21", "published_display": "02 Jul 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical Technology Holdings announces EoW agreements", "summary": "Creative Medical Technology Holdings, Inc. has entered into agreements with warrant holders for the immediate exercise of outstanding warrants, originally issued in October 2025, at a reduced exercise price of $1.60 per share, generating approximately $4.5 million in gross procee", "url": "https://medicalbuyer.co.in/creative-medical-technology-holdings-announces-eow-agreements/", "source_name": "Medical Buyer", "published_at": "2026-07-02T15:39:22", "published_display": "02 Jul 2026 15:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical Technology Holdings Inc. (CELZ) Stock Price | Live Quotes & Charts | NASDAQ", "summary": "This page provides live stock quotes and charts for Creative Medical Technology Holdings Inc. (CELZ) on NASDAQ. It shows the current stock price, recent change, and offers a chart for various timeframes. The article also notes the absence of current analyst ratings and earnings i", "url": "https://stockstotrade.com/quote/CELZ", "source_name": "StocksToTrade", "published_at": "2026-07-02T08:39:21", "published_display": "02 Jul 2026 08:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical (CELZ) asks shareholders to OK 5.58M warrants, 100M cap increase", "summary": "Creative Medical Technology Holdings, Inc. (CELZ) is seeking shareholder approval for two proposals at a Special Meeting: to increase authorized common stock from 25 million to 100 million shares and to approve the exercise of 5.58 million Investor Warrants at $1.60 per share. Th", "url": "https://www.stocktitan.net/sec-filings/CELZ/pre-14a-creative-medical-technology-holdings-inc-preliminary-proxy-st-71f6acf99626.html", "source_name": "Stock Titan", "published_at": "2026-07-01T21:09:29", "published_display": "01 Jul 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical says FDA-cleared pain trial is 85% enrolled", "summary": "Creative Medical Technology Holdings (NASDAQ: CELZ) provided a mid-year update for 2026, highlighting significant progress in its regenerative medicine and AI-enabled biodefense programs. The company reported that its Olastrocel (CELZ-201) treatment for chronic lower back pain sh", "url": "https://www.stocktitan.net/news/CELZ/creative-medical-technology-holdings-issues-mid-year-x7harg4h1fem.html", "source_name": "Stock Titan", "published_at": "2026-07-01T13:09:29", "published_display": "01 Jul 2026 13:09", "sentiment": "positive", "sentiment_pct": 77, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical Technology Holdings Issues Mid-Year Update", "summary": "Creative Medical Technology Holdings, Inc. provided a mid-year update highlighting significant clinical, regulatory, and strategic progress across its core programs, including Olastrocel for chronic lower back pain, Ultrasome for osteoarthritis, and the CELZ-Biodefense Platform. ", "url": "https://www.manilatimes.net/2026/07/01/tmt-newswire/globenewswire/creative-medical-technology-holdings-issues-mid-year-update/2376768", "source_name": "The Manila Times", "published_at": "2026-07-01T10:00:00", "published_display": "01 Jul 2026 10:00", "sentiment": "positive", "sentiment_pct": 93, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.5 Million Gross Proceeds", "summary": "Creative Medical Technology Holdings (Nasdaq: CELZ) announced agreements with certain warrant holders for the immediate exercise of existing warrants, generating approximately $4.5 million in gross proceeds. The company will issue new unregistered warrants upon the receipt of sha", "url": "https://www.manilatimes.net/2026/07/01/tmt-newswire/globenewswire/creative-medical-technology-holdings-announces-agreements-for-exercise-of-warrants-for-45-million-gross-proceeds/2376195/amp", "source_name": "The Manila Times", "published_at": "2026-07-01T08:41:07", "published_display": "01 Jul 2026 08:41", "sentiment": "positive", "sentiment_pct": 76, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical (CELZ) Secures $4.5M from Immediate Warrant Exercises", "summary": "Creative Medical Technology Holdings Inc (CELZ) has announced it will receive approximately $4.5 million in gross proceeds from immediate warrant exercises by existing warrant holders. The company will issue new unregistered warrants for an additional 5,580,680 shares. Despite th", "url": "https://www.gurufocus.com/news/8939228/creative-medical-celz-secures-45m-from-immediate-warrant-exercises", "source_name": "GuruFocus", "published_at": "2026-06-30T18:41:13", "published_display": "30 Jun 2026 18:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical Technology Holdings Announces Immediate Exercise of Warrants for Approximately $4.5 Million in Gross Proceeds", "summary": "Creative Medical Technology Holdings (CELZ) announced agreements for the immediate exercise of warrants, expecting to raise about $4.5 million in gross proceeds. This funding, from warrant holders exercising at a reduced price of $1.60 per share, will be used for working capital ", "url": "https://www.quiverquant.com/news/Creative+Medical+Technology+Holdings+Announces+Immediate+Exercise+of+Warrants+for+Approximately+%244.5+Million+in+Gross+Proceeds", "source_name": "Quiver Quantitative", "published_at": "2026-06-30T18:41:07", "published_display": "30 Jun 2026 18:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical locks in $4.5M from warrant holders", "summary": "Creative Medical Technology Holdings (CELZ) has secured approximately $4.5 million in gross proceeds through agreements for the immediate exercise of existing warrants at a reduced price of $1.60 per share. In exchange, the company will issue new, unregistered warrants for up to ", "url": "https://www.stocktitan.net/news/CELZ/creative-medical-technology-holdings-announces-agreements-for-zbrzgzi4sm63.html", "source_name": "Stock Titan", "published_at": "2026-06-30T17:41:13", "published_display": "30 Jun 2026 17:41", "sentiment": "negative", "sentiment_pct": 32, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "12 Health Care Stocks Moving In Tuesday's Intraday Session", "summary": "This article identifies 12 healthcare stocks that experienced significant price movements during Tuesday's intraday trading session. It lists several gainers including Creative Medical Technologies, Cuprina Holdings, Abivax, C4 Therapeutics, Bio Green Med Solution, and ProMIS Neu", "url": "https://www.benzinga.com/trading-ideas/movers/26/06/60196206/12-health-care-stocks-moving-tuesday-s-intraday-session", "source_name": "Benzinga", "published_at": "2026-06-30T16:41:13", "published_display": "30 Jun 2026 16:41", "sentiment": "positive", "sentiment_pct": 76, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[RW] CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. SEC Filing", "summary": "Creative Medical Technology Holdings, Inc. has filed a request to withdraw its registration statement on Form S-1, which was filed on June 25, 2026. The company no longer plans to proceed with the offering of its securities described in the registration statement. They also reque", "url": "https://www.stocktitan.net/sec-filings/CELZ/rw-creative-medical-technology-holdings-inc-sec-filing-256f4ff869de.html", "source_name": "Stock Titan", "published_at": "2026-06-30T12:41:13", "published_display": "30 Jun 2026 12:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CELZ Stock Jumps As FDA Clears Expanded Pain Trial", "summary": "Creative Medical Technology Holdings Inc. (CELZ) stock surged by over 380% after the FDA cleared an expansion of its ADAPT Phase 2 trial for CELZ-201, a treatment for chronic lower back pain. The expansion includes an additional 15 patients on lower-dose opioids, with enrollment ", "url": "https://stockstotrade.com/news/creative-medical-technology-holdings-inc-celz-news-2026_06_30/", "source_name": "StocksToTrade", "published_at": "2026-06-30T10:04:00", "published_display": "30 Jun 2026 10:04", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical Technology (CELZ) Plunges 32.5% as Selling Pressure Intensifies - AAII Bearish", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxQVHJyOHUtOU9kaDdiZWlhVjYwYjZqQ3YySnNFWVNxS09HcndjZHNHNUtMZUVKV0tCRGV4b0hmdzlqUFI3T1hTWjZVZkZ5OHVMeVZaalFsSE9NelA3SWRwQnVGa25wYkExQ1pPT3VYd0dPS092bDlGQXoxb1J3eXFpeXd2RXpobDhlaV80cTdpVmU1eWRPRTloS0JXU0NoVmZ5dUtjanFlUFA2akdNMUdldEtYM2tsb2JKWWtHQw?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-30T01:34:10+00:00", "published_display": "30 Jun 2026 01:34", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nasdaq Falls Over 200 Points; US Goods Trade Gap Widens In May - Creative Medical Tech (NASDAQ:CELZ), Sad", "summary": "U.S. stocks, especially the Nasdaq, experienced a significant dip on Friday, with the goods trade deficit widening to $105.8 billion in May, exceeding expectations. Healthcare shares saw gains while information technology stocks declined. Several individual stocks, including Sado", "url": "https://www.benzinga.com/news/26/06/60126400/nasdaq-falls-over-200-points-us-goods-trade-gap-widens-in-may", "source_name": "Benzinga", "published_at": "2026-06-27T08:40:22", "published_display": "27 Jun 2026 08:40", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[S-1/A] CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. Amends IPO Registration Statement", "summary": "Creative Medical Technology Holdings, Inc. has amended its S-1 IPO registration statement, seeking to register 3,045,685 shares of common stock, 6,091,371 Public Warrants, and 3,045,685 pre-funded warrants. The offering, aiming for estimated net proceeds of $5.34 million, will fu", "url": "https://www.stocktitan.net/sec-filings/CELZ/s-1-a-creative-medical-technology-holdings-inc-amends-ipo-registratio-aa17ad6c26f1.html", "source_name": "Stock Titan", "published_at": "2026-06-26T20:41:02", "published_display": "26 Jun 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form S-1/A Creative Medical Technology Holdings Inc For: 26 June By Investing.com", "summary": "Investing.com reported on the Form S-1/A filing by Creative Medical Technology Holdings Inc for June 26. The article also included a standard disclaimer about the high risks involved in trading financial instruments and cryptocurrencies, emphasizing that data on their website may", "url": "https://m.au.investing.com/news/stock-market-news/form-s1a-creative-medical-technology-holdings-inc-for-26-june-93CH-4507296?ampMode=1", "source_name": "Investing.com Australia", "published_at": "2026-06-26T20:41:02", "published_display": "26 Jun 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical Technology Holdings, Inc. Actuals & Estimates (NASDAQ:CELZ)", "summary": "This article provides a financial overview and analyst estimates for Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ). It covers the company's current stock price, recent performance, future forecasts, historical highs and lows, volatility, market capitalization, and upco", "url": "https://www.tradingview.com/symbols/NASDAQ-CELZ/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T20:41:02", "published_display": "26 Jun 2026 20:41", "sentiment": "negative", "sentiment_pct": 27, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical Technology Holdings, Inc. Actuals & Estimates (BOATS:CELZ)", "summary": "This article provides an overview of Creative Medical Technology Holdings, Inc. (CELZ) stock, including its financial actuals and estimates. It addresses frequently asked questions regarding the stock ticker, forecast, historical prices, earnings reports, revenue, net income, div", "url": "https://www.tradingview.com/symbols/BOATS-CELZ/forecast-actuals-and-estimates/?category=cash_flow", "source_name": "TradingView", "published_at": "2026-06-26T17:40:24", "published_display": "26 Jun 2026 17:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Creative Medical Technology Holdings, Inc. \u2013 NASDAQ:CELZ", "summary": "The article describes a financial data point for Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), specifically its Enterprise value to EBIT forward. It is presented in the context of TradingView, a platform offering various financial tools and market data.", "url": "https://www.tradingview.com/symbols/NASDAQ-CELZ/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T09:40:24", "published_display": "26 Jun 2026 09:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CELZ Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast and price target for Creative Medical Technology Holdings, Inc. (CELZ) stock, indicating a 1-year price forecast of $20.00 from one analyst. It also details recent stock performance, company financials, earnings estimates, market capitalization, a", "url": "https://www.tradingview.com/symbols/NASDAQ-CELZ/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T07:41:02", "published_display": "26 Jun 2026 07:41", "sentiment": "negative", "sentiment_pct": 18, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Number of shareholders of Creative Medical Technology Holdings, Inc. \u2013 NASDAQ:CELZ", "summary": "This article focuses on Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) and provides information about the number of its shareholders. The content appears to be a stub or a section within a larger financial data platform, indicating where the shareholder data would typi", "url": "https://www.tradingview.com/symbols/NASDAQ-CELZ/financials-statistics-and-ratios/number-of-shareholders/", "source_name": "TradingView", "published_at": "2026-06-26T01:12:25", "published_display": "26 Jun 2026 01:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical Technology Holdings Files to Offer Up 3.05M Shrs and Up to 6.09M Warrants", "summary": "Creative Medical Technology Holdings (CMT.A) has filed to offer up to 3.05 million shares of common stock and up to 6.09 million warrants. This move indicates potential capital raising or restructuring activities for the company. Investors will be watching for further details reg", "url": "https://www.moomoo.com/news/post/72059686/creative-medical-technology-holdings-files-to-offer-up-3-05m?futusource=news_newspage_recommend", "source_name": "Moomoo", "published_at": "2026-06-25T23:12:25", "published_display": "25 Jun 2026 23:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical (NASDAQ: CELZ) plans $5.3M stock and warrant raise", "summary": "Creative Medical Technology Holdings (NASDAQ: CELZ) is planning a public offering to raise approximately $5.3 million through the sale of common stock and warrants. The company intends to use the net proceeds to fund its clinical programs, including the CELZ-201 ADAPT back pain t", "url": "https://www.stocktitan.net/sec-filings/CELZ/s-1-creative-medical-technology-holdings-inc-files-ipo-registration-s-6c72187e48c0.html", "source_name": "Stock Titan", "published_at": "2026-06-25T20:12:25", "published_display": "25 Jun 2026 20:12", "sentiment": "negative", "sentiment_pct": 41, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FDA Clears Olastrocel Trial Expansion", "summary": "The FDA has cleared an expansion of Creative Medical Technology Holdings, Inc.'s ADAPT clinical trial for CELZ-201 (Olastrocel), which evaluates the treatment for chronic lower back pain associated with degenerative disc disease. An additional 15 patients with ongoing opioid use ", "url": "https://www.conexiant.com/Radiology/viewarticle?id=0e029f52-283b-4902-a27c-c1b0ded76b61&pub=Conexiant", "source_name": "Conexiant", "published_at": "2026-06-24T02:49:48", "published_display": "24 Jun 2026 02:49", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical Technology Holdings Expands ADAPT Trial Under New FDA Clearance and Rapidly Advances Toward Phase 3 Planning for Olastrocel in Chronic Lower Back Pain", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/creative-medical-technology-holdings-expands-131500392.html", "source_name": "GlobeNewswire", "published_at": "2026-06-22T13:15:00+00:00", "published_display": "22 Jun 2026 13:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical gets FDA clearance to add 15 patients in Olastrocel trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOa2djaUZiMUpVQVRPMVl0LW0xbTZ5eTRBdTY3QnktVGlfNHJGUDhUNjA0Z2RLS2NyQzR0dWZqWUl2em1GOWI2U2Z5SV91aVoxSW8yT096QzA5RVZZOFE4NjNhWnJhNDdtSmoxUzc5OXVpa1FKdUN1TzJ2UHloalEycGdzME80WU45ZjVBQ3JFTTkzcEw0XzJ0Y0FtVzZuWXRBSFBHVUxDUEhSb2paRUhqRVZEY3hDNDl5NVlUdFFB?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical Technology opens nationwide burn-pit data registry", "summary": "", "url": "https://finance.yahoo.com/m/0455d054-b6ad-3295-ac60-d9f0da8224cf/creative-medical-technology.html", "source_name": "Proactive", "published_at": "2026-06-16T19:49:00+00:00", "published_display": "16 Jun 2026 19:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical Technology Holdings, Inc. Advances Project PHOENIX into Nationwide AI Driven Virtual Data Collection Phase for U.S. Veterans Exposed to Burn Pits and Toxic Hazards", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/creative-medical-technology-holdings-inc-130000192.html", "source_name": "GlobeNewswire", "published_at": "2026-06-16T13:00:00+00:00", "published_display": "16 Jun 2026 13:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical Technology (CELZ) Slips 4.6% as Stock Approaches Key Support - Algorithmic Stock Picks", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPS0I0LXc2OTdnYWI5UjhIdGhocXUySGdES184R0R3MUQ1V05WenRJeExXeElMdzMyaDZwUlRxSGVYRkJfN3AzZElQcnVjWDg1Yl8tOU1PWnBwX2ZVTkNrWlp3STE5YzNKQlVsQldOTWZhb0duYnV1SVVUMEtpeS1GNTRXLTJRWFJVRTQ0UzBydGNNaDU1aHRGMXlfdnlERE1DVjdYZDRHM0o0eUdCalZjRl84TUswaEptQXE1UQ?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical Technology (CELZ) Edges Lower by 0.22% as Stock Consolidates Between Key Levels - Calendar Spread Trade", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxPeDhqdHYzaVQzY2YzS21LazZlNXUtSlVDbHRyOGwzWkpDelNlVWh4Ym9sREtDX1RVRFVNVTNVQkMwd2hsTXljdnVNSWVqaUMycGJPUkY1UUR4bGVLaWlWeEpHVHNIdnMzcWJZYUg4RnlBbGFxSWNfNGJ3MTV0LU1XbGdXaGY0ZFF4R0Q3c2FXWHdiWEI0QUs1aTltdVdVRkwwUndVLTNQTE92d1pVaHZNSENfN3pCQlF3dXRtN04tX3dQRm5OYmFkRlpuSExyWjI3bmc?oc=5", "source_name": "dars.gov.et", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical Technology Holdings (CELZ) Slips 1.3% as Stock Tests Key Support at $2.17 - Gap Up Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxNMTRVeHQ1STJWa0FqRDN1aTFwT0I5QzlwSGViS0pHTTJZY0lsbjFYT01RTFlJanhqUnM4SFowbExic0oySWs2NWYzY01YVmFVZXZhSTlmZ1JVay1YQ280WEE2dUZuZEtVbnJGVUZqUDNPWG1EUXl2SGxVTkh1OGQtRktGaVJMQlNxX3Vud1ktS0RSYW9kaFpTU0ZOR2FzT1QzSk82MHNBanNJSDJZQVVzWXQtX1lSOE01RS1NRU40VmJzOWc0NVQxSk1KOG4?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Creative Medical Technology Holdings, Inc. Reports Breakthrough 93% Response Rate in Ultrasome\u2122 Knee Osteoarthritis Program, Expanding CELZ-201 Platform into Scalable Cell-Free Regenerative Therapies", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/creative-medical-technology-holdings-inc-130100026.html", "source_name": "GlobeNewswire", "published_at": "2026-04-28T13:01:00+00:00", "published_display": "28 Apr 2026 13:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Analysts Expect Breakeven For Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Before Long", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQTElwYTlpVVFTRVhmUkpxZDh0RUdUcUd3RnJwOEx3c0MtUml1ZkVSdktpcktqaFdja1pNS0RaaWxLaUtzVmw4RFJaUGdsaHJZWWQtWFNpTFREVThjcDB4NUdGUVV0WjlxcjVlSUE0YkNOSHFZNnRJUjBFOGZlb1d3Z3Brb1MzdXlmaFU5T19oTTZLZEN0WlB3dTF1YXJqSVJNNmc1NGtwcWx3cWJaQ19SYw?oc=5", "source_name": "Market source", "published_at": "2026-04-09T07:00:00+00:00", "published_display": "09 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Day 6 of Gains Streak for Creative Medical Technology Stock with 43% Return (vs. 123% YTD) [10/27/2025]", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-wFBVV95cUxQMFlhZTg3aHZ0eXo5RXl5VmdxVElabFBHWHRuRENpdzNteFRDcVlYTEpvUjl1cWZSRXdpMFA3VnJlUTZSc2xfU29LVktsNEVhUVQ3WG9IVktiak9tQ0ZwazFnQ2NzNS1BS1FVQzg3NGhSbFNWbzVpcnRLVFpSS09GZ01CNng1eHR0blBleElmbFU5bmNxWEdBZmdMSGRvZ1FzOTk3VTE4b2tKYXBXbmNIZDBxYVhOa0NwMDNEREEyM2sya0JsVzE4WjVkSUoxNnpzSXlyX2cwRVdDMS1DMW9MMkNkTml5WHRtem9qQVlLYXAzcC14eWVWYVdRRQ?oc=5", "source_name": "Trefis", "published_at": "2025-10-27T07:00:00+00:00", "published_display": "27 Oct 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should I buy Creative Medical Technology Holdings, Inc. (CELZ)", "summary": "", "url": "https://news.google.com/rss/articles/CBMibEFVX3lxTE8tTGRCLVAyTUtsVGgwc3c0RjNoWnpLU3BDcnJVZjZ2bm5UVFhYT0dkdEllaG5QM1YyVnpEeU1DbzZjWWZHbXlUaTNyUXlvU0NoY3lqREhPS2xZMkxCTmFGVHFTLTV1bGNtdDVtMA?oc=5", "source_name": "Zacks Investment Research", "published_at": "2025-07-31T07:00:00+00:00", "published_display": "31 Jul 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What is the current Price Target and Forecast for Creative Medical Technology Holdings, Inc. (CELZ)", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTE9NQnRQVVl2Q0loeGY5NVY0cXF6bTI2emdBNVAwMTV0bUE0eEpUbk94MW5ZSFRyY01TVzFSODlNWFVrYW1xUE56cUFVOFRESDA3clJGaU1RMTRBaTBkMWNqcXVaQmdiekE4VWRCMzBDR1ZieGhGYkRfSg?oc=5", "source_name": "Zacks Investment Research", "published_at": "2022-07-29T00:34:36+00:00", "published_display": "29 Jul 2022 00:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CELZ Stock Price and Chart \u2014 NASDAQ:CELZ", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE9RSFotU1ROSjY4Z2hTdW9UUmNHeXJfOUN3V0ZYeThjVHV3RzQtVGxEbWpLWHBURmNVYzY3ZnRTM25Ud3REdjc3QUFJUVJ6QW9VVnhyZjhLX2lyb0Fh?oc=5", "source_name": "TradingView", "published_at": "2022-03-24T07:00:00+00:00", "published_display": "24 Mar 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Creative Medical Technology (CELZ) plans big share boost and warrant approval", "summary": "Creative Medical Technology Holdings, Inc. (CELZ) is calling a special stockholder meeting on August 28, 2026, to vote on two key proposals. These include increasing authorized common stock from 25 million to 100 million shares and approving the full exercise of private-placement", "url": "https://www.stocktitan.net/sec-filings/CELZ/def-14a-creative-medical-technology-holdings-inc-definitive-proxy-sta-da99175a72f4.html", "source_name": "Stock Titan", "published_at": "2026-07-14T19:49:48", "published_display": "14 Jul 2026 19:49", "sentiment": "negative", "sentiment_pct": 40, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical Technology enters into agreement with existing warrant holders", "summary": "Creative Medical Technology Holdings, Inc. entered into inducement agreements with existing warrant holders, lowering the exercise price from $2.86 to $1.60 per share, which led to the exercise of warrants covering 2,790,340 common shares and raised approximately $4.5 million. Th", "url": "https://medicalbuyer.co.in/creative-medical-technology-enters-into-agreement-with-existing-warrant-holders/", "source_name": "Medical Buyer", "published_at": "2026-07-06T08:12:11", "published_display": "06 Jul 2026 08:12", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical Technology Raises $4.5M From Warrant Exercises, Reprices and Issues New 5-Year Warrants", "summary": "Creative Medical Technology (CELZ) has reportedly raised approximately $4.5 million in gross proceeds through warrant exercise inducement letters with existing warrant holders. The company reduced the exercise price from $2.86 to $1.60 per share, and in return, will issue new ind", "url": "https://www.tradingview.com/news/tradingview:c96d2de670ac5:0-creative-medical-technology-raises-4-5m-from-warrant-exercises-reprices-and-issues-new-5-year-warrants/", "source_name": "TradingView", "published_at": "2026-07-03T11:10:00", "published_display": "03 Jul 2026 11:10", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical Technology awards $100,000 bonus to CEO Timothy Warbington", "summary": "Creative Medical Technology Holdings (CELZ) has awarded its CEO, Timothy Warbington, a bonus of $100,000. The bonus was approved by the board's Compensation Committee and became effective on July 1, 2026. The information was sourced from an SEC 8-K filing.", "url": "https://www.tradingview.com/news/tradingview:e88da564db662:0-creative-medical-technology-awards-100-000-bonus-to-ceo-timothy-warbington/", "source_name": "TradingView", "published_at": "2026-07-02T20:39:21", "published_display": "02 Jul 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical (CELZ) secures $4.5M and issues 5.58M inducement warrants", "summary": "Creative Medical Technology Holdings (CELZ) has secured approximately $4.5 million in gross proceeds through an inducement offer, encouraging warrant holders to exercise 2,790,340 existing warrants at a reduced price of $1.60 per share. In exchange, the company issued 5,580,680 n", "url": "https://www.stocktitan.net/sec-filings/CELZ/8-k-creative-medical-technology-holdings-inc-reports-material-event-3937323446b5.html", "source_name": "Stock Titan", "published_at": "2026-07-02T20:39:21", "published_display": "02 Jul 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical Technology Holdings announces EoW agreements", "summary": "Creative Medical Technology Holdings, Inc. has entered into agreements with warrant holders for the immediate exercise of outstanding warrants, originally issued in October 2025, at a reduced exercise price of $1.60 per share, generating approximately $4.5 million in gross procee", "url": "https://medicalbuyer.co.in/creative-medical-technology-holdings-announces-eow-agreements/", "source_name": "Medical Buyer", "published_at": "2026-07-02T15:39:22", "published_display": "02 Jul 2026 15:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical Technology Holdings Inc. (CELZ) Stock Price | Live Quotes & Charts | NASDAQ", "summary": "This page provides live stock quotes and charts for Creative Medical Technology Holdings Inc. (CELZ) on NASDAQ. It shows the current stock price, recent change, and offers a chart for various timeframes. The article also notes the absence of current analyst ratings and earnings i", "url": "https://stockstotrade.com/quote/CELZ", "source_name": "StocksToTrade", "published_at": "2026-07-02T08:39:21", "published_display": "02 Jul 2026 08:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical (CELZ) asks shareholders to OK 5.58M warrants, 100M cap increase", "summary": "Creative Medical Technology Holdings, Inc. (CELZ) is seeking shareholder approval for two proposals at a Special Meeting: to increase authorized common stock from 25 million to 100 million shares and to approve the exercise of 5.58 million Investor Warrants at $1.60 per share. Th", "url": "https://www.stocktitan.net/sec-filings/CELZ/pre-14a-creative-medical-technology-holdings-inc-preliminary-proxy-st-71f6acf99626.html", "source_name": "Stock Titan", "published_at": "2026-07-01T21:09:29", "published_display": "01 Jul 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical says FDA-cleared pain trial is 85% enrolled", "summary": "Creative Medical Technology Holdings (NASDAQ: CELZ) provided a mid-year update for 2026, highlighting significant progress in its regenerative medicine and AI-enabled biodefense programs. The company reported that its Olastrocel (CELZ-201) treatment for chronic lower back pain sh", "url": "https://www.stocktitan.net/news/CELZ/creative-medical-technology-holdings-issues-mid-year-x7harg4h1fem.html", "source_name": "Stock Titan", "published_at": "2026-07-01T13:09:29", "published_display": "01 Jul 2026 13:09", "sentiment": "positive", "sentiment_pct": 77, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical Technology Holdings Issues Mid-Year Update", "summary": "Creative Medical Technology Holdings, Inc. provided a mid-year update highlighting significant clinical, regulatory, and strategic progress across its core programs, including Olastrocel for chronic lower back pain, Ultrasome for osteoarthritis, and the CELZ-Biodefense Platform. ", "url": "https://www.manilatimes.net/2026/07/01/tmt-newswire/globenewswire/creative-medical-technology-holdings-issues-mid-year-update/2376768", "source_name": "The Manila Times", "published_at": "2026-07-01T10:00:00", "published_display": "01 Jul 2026 10:00", "sentiment": "positive", "sentiment_pct": 93, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.5 Million Gross Proceeds", "summary": "Creative Medical Technology Holdings (Nasdaq: CELZ) announced agreements with certain warrant holders for the immediate exercise of existing warrants, generating approximately $4.5 million in gross proceeds. The company will issue new unregistered warrants upon the receipt of sha", "url": "https://www.manilatimes.net/2026/07/01/tmt-newswire/globenewswire/creative-medical-technology-holdings-announces-agreements-for-exercise-of-warrants-for-45-million-gross-proceeds/2376195/amp", "source_name": "The Manila Times", "published_at": "2026-07-01T08:41:07", "published_display": "01 Jul 2026 08:41", "sentiment": "positive", "sentiment_pct": 76, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical (CELZ) Secures $4.5M from Immediate Warrant Exercises", "summary": "Creative Medical Technology Holdings Inc (CELZ) has announced it will receive approximately $4.5 million in gross proceeds from immediate warrant exercises by existing warrant holders. The company will issue new unregistered warrants for an additional 5,580,680 shares. Despite th", "url": "https://www.gurufocus.com/news/8939228/creative-medical-celz-secures-45m-from-immediate-warrant-exercises", "source_name": "GuruFocus", "published_at": "2026-06-30T18:41:13", "published_display": "30 Jun 2026 18:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical Technology Holdings Announces Immediate Exercise of Warrants for Approximately $4.5 Million in Gross Proceeds", "summary": "Creative Medical Technology Holdings (CELZ) announced agreements for the immediate exercise of warrants, expecting to raise about $4.5 million in gross proceeds. This funding, from warrant holders exercising at a reduced price of $1.60 per share, will be used for working capital ", "url": "https://www.quiverquant.com/news/Creative+Medical+Technology+Holdings+Announces+Immediate+Exercise+of+Warrants+for+Approximately+%244.5+Million+in+Gross+Proceeds", "source_name": "Quiver Quantitative", "published_at": "2026-06-30T18:41:07", "published_display": "30 Jun 2026 18:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical locks in $4.5M from warrant holders", "summary": "Creative Medical Technology Holdings (CELZ) has secured approximately $4.5 million in gross proceeds through agreements for the immediate exercise of existing warrants at a reduced price of $1.60 per share. In exchange, the company will issue new, unregistered warrants for up to ", "url": "https://www.stocktitan.net/news/CELZ/creative-medical-technology-holdings-announces-agreements-for-zbrzgzi4sm63.html", "source_name": "Stock Titan", "published_at": "2026-06-30T17:41:13", "published_display": "30 Jun 2026 17:41", "sentiment": "negative", "sentiment_pct": 32, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "12 Health Care Stocks Moving In Tuesday's Intraday Session", "summary": "This article identifies 12 healthcare stocks that experienced significant price movements during Tuesday's intraday trading session. It lists several gainers including Creative Medical Technologies, Cuprina Holdings, Abivax, C4 Therapeutics, Bio Green Med Solution, and ProMIS Neu", "url": "https://www.benzinga.com/trading-ideas/movers/26/06/60196206/12-health-care-stocks-moving-tuesday-s-intraday-session", "source_name": "Benzinga", "published_at": "2026-06-30T16:41:13", "published_display": "30 Jun 2026 16:41", "sentiment": "positive", "sentiment_pct": 76, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[RW] CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. SEC Filing", "summary": "Creative Medical Technology Holdings, Inc. has filed a request to withdraw its registration statement on Form S-1, which was filed on June 25, 2026. The company no longer plans to proceed with the offering of its securities described in the registration statement. They also reque", "url": "https://www.stocktitan.net/sec-filings/CELZ/rw-creative-medical-technology-holdings-inc-sec-filing-256f4ff869de.html", "source_name": "Stock Titan", "published_at": "2026-06-30T12:41:13", "published_display": "30 Jun 2026 12:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CELZ Stock Jumps As FDA Clears Expanded Pain Trial", "summary": "Creative Medical Technology Holdings Inc. (CELZ) stock surged by over 380% after the FDA cleared an expansion of its ADAPT Phase 2 trial for CELZ-201, a treatment for chronic lower back pain. The expansion includes an additional 15 patients on lower-dose opioids, with enrollment ", "url": "https://stockstotrade.com/news/creative-medical-technology-holdings-inc-celz-news-2026_06_30/", "source_name": "StocksToTrade", "published_at": "2026-06-30T10:04:00", "published_display": "30 Jun 2026 10:04", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical Technology (CELZ) Plunges 32.5% as Selling Pressure Intensifies - AAII Bearish", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxQVHJyOHUtOU9kaDdiZWlhVjYwYjZqQ3YySnNFWVNxS09HcndjZHNHNUtMZUVKV0tCRGV4b0hmdzlqUFI3T1hTWjZVZkZ5OHVMeVZaalFsSE9NelA3SWRwQnVGa25wYkExQ1pPT3VYd0dPS092bDlGQXoxb1J3eXFpeXd2RXpobDhlaV80cTdpVmU1eWRPRTloS0JXU0NoVmZ5dUtjanFlUFA2akdNMUdldEtYM2tsb2JKWWtHQw?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-30T01:34:10+00:00", "published_display": "30 Jun 2026 01:34", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nasdaq Falls Over 200 Points; US Goods Trade Gap Widens In May - Creative Medical Tech (NASDAQ:CELZ), Sad", "summary": "U.S. stocks, especially the Nasdaq, experienced a significant dip on Friday, with the goods trade deficit widening to $105.8 billion in May, exceeding expectations. Healthcare shares saw gains while information technology stocks declined. Several individual stocks, including Sado", "url": "https://www.benzinga.com/news/26/06/60126400/nasdaq-falls-over-200-points-us-goods-trade-gap-widens-in-may", "source_name": "Benzinga", "published_at": "2026-06-27T08:40:22", "published_display": "27 Jun 2026 08:40", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[S-1/A] CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. Amends IPO Registration Statement", "summary": "Creative Medical Technology Holdings, Inc. has amended its S-1 IPO registration statement, seeking to register 3,045,685 shares of common stock, 6,091,371 Public Warrants, and 3,045,685 pre-funded warrants. The offering, aiming for estimated net proceeds of $5.34 million, will fu", "url": "https://www.stocktitan.net/sec-filings/CELZ/s-1-a-creative-medical-technology-holdings-inc-amends-ipo-registratio-aa17ad6c26f1.html", "source_name": "Stock Titan", "published_at": "2026-06-26T20:41:02", "published_display": "26 Jun 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form S-1/A Creative Medical Technology Holdings Inc For: 26 June By Investing.com", "summary": "Investing.com reported on the Form S-1/A filing by Creative Medical Technology Holdings Inc for June 26. The article also included a standard disclaimer about the high risks involved in trading financial instruments and cryptocurrencies, emphasizing that data on their website may", "url": "https://m.au.investing.com/news/stock-market-news/form-s1a-creative-medical-technology-holdings-inc-for-26-june-93CH-4507296?ampMode=1", "source_name": "Investing.com Australia", "published_at": "2026-06-26T20:41:02", "published_display": "26 Jun 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical Technology Holdings, Inc. Actuals & Estimates (NASDAQ:CELZ)", "summary": "This article provides a financial overview and analyst estimates for Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ). It covers the company's current stock price, recent performance, future forecasts, historical highs and lows, volatility, market capitalization, and upco", "url": "https://www.tradingview.com/symbols/NASDAQ-CELZ/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T20:41:02", "published_display": "26 Jun 2026 20:41", "sentiment": "negative", "sentiment_pct": 27, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical Technology Holdings, Inc. Actuals & Estimates (BOATS:CELZ)", "summary": "This article provides an overview of Creative Medical Technology Holdings, Inc. (CELZ) stock, including its financial actuals and estimates. It addresses frequently asked questions regarding the stock ticker, forecast, historical prices, earnings reports, revenue, net income, div", "url": "https://www.tradingview.com/symbols/BOATS-CELZ/forecast-actuals-and-estimates/?category=cash_flow", "source_name": "TradingView", "published_at": "2026-06-26T17:40:24", "published_display": "26 Jun 2026 17:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Creative Medical Technology Holdings, Inc. \u2013 NASDAQ:CELZ", "summary": "The article describes a financial data point for Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), specifically its Enterprise value to EBIT forward. It is presented in the context of TradingView, a platform offering various financial tools and market data.", "url": "https://www.tradingview.com/symbols/NASDAQ-CELZ/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T09:40:24", "published_display": "26 Jun 2026 09:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CELZ Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast and price target for Creative Medical Technology Holdings, Inc. (CELZ) stock, indicating a 1-year price forecast of $20.00 from one analyst. It also details recent stock performance, company financials, earnings estimates, market capitalization, a", "url": "https://www.tradingview.com/symbols/NASDAQ-CELZ/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T07:41:02", "published_display": "26 Jun 2026 07:41", "sentiment": "negative", "sentiment_pct": 18, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Number of shareholders of Creative Medical Technology Holdings, Inc. \u2013 NASDAQ:CELZ", "summary": "This article focuses on Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) and provides information about the number of its shareholders. The content appears to be a stub or a section within a larger financial data platform, indicating where the shareholder data would typi", "url": "https://www.tradingview.com/symbols/NASDAQ-CELZ/financials-statistics-and-ratios/number-of-shareholders/", "source_name": "TradingView", "published_at": "2026-06-26T01:12:25", "published_display": "26 Jun 2026 01:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical Technology Holdings Files to Offer Up 3.05M Shrs and Up to 6.09M Warrants", "summary": "Creative Medical Technology Holdings (CMT.A) has filed to offer up to 3.05 million shares of common stock and up to 6.09 million warrants. This move indicates potential capital raising or restructuring activities for the company. Investors will be watching for further details reg", "url": "https://www.moomoo.com/news/post/72059686/creative-medical-technology-holdings-files-to-offer-up-3-05m?futusource=news_newspage_recommend", "source_name": "Moomoo", "published_at": "2026-06-25T23:12:25", "published_display": "25 Jun 2026 23:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical (NASDAQ: CELZ) plans $5.3M stock and warrant raise", "summary": "Creative Medical Technology Holdings (NASDAQ: CELZ) is planning a public offering to raise approximately $5.3 million through the sale of common stock and warrants. The company intends to use the net proceeds to fund its clinical programs, including the CELZ-201 ADAPT back pain t", "url": "https://www.stocktitan.net/sec-filings/CELZ/s-1-creative-medical-technology-holdings-inc-files-ipo-registration-s-6c72187e48c0.html", "source_name": "Stock Titan", "published_at": "2026-06-25T20:12:25", "published_display": "25 Jun 2026 20:12", "sentiment": "negative", "sentiment_pct": 41, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FDA Clears Olastrocel Trial Expansion", "summary": "The FDA has cleared an expansion of Creative Medical Technology Holdings, Inc.'s ADAPT clinical trial for CELZ-201 (Olastrocel), which evaluates the treatment for chronic lower back pain associated with degenerative disc disease. An additional 15 patients with ongoing opioid use ", "url": "https://www.conexiant.com/Radiology/viewarticle?id=0e029f52-283b-4902-a27c-c1b0ded76b61&pub=Conexiant", "source_name": "Conexiant", "published_at": "2026-06-24T02:49:48", "published_display": "24 Jun 2026 02:49", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical Technology Holdings Expands ADAPT Trial Under New FDA Clearance and Rapidly Advances Toward Phase 3 Planning for Olastrocel in Chronic Lower Back Pain", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/creative-medical-technology-holdings-expands-131500392.html", "source_name": "GlobeNewswire", "published_at": "2026-06-22T13:15:00+00:00", "published_display": "22 Jun 2026 13:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical gets FDA clearance to add 15 patients in Olastrocel trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOa2djaUZiMUpVQVRPMVl0LW0xbTZ5eTRBdTY3QnktVGlfNHJGUDhUNjA0Z2RLS2NyQzR0dWZqWUl2em1GOWI2U2Z5SV91aVoxSW8yT096QzA5RVZZOFE4NjNhWnJhNDdtSmoxUzc5OXVpa1FKdUN1TzJ2UHloalEycGdzME80WU45ZjVBQ3JFTTkzcEw0XzJ0Y0FtVzZuWXRBSFBHVUxDUEhSb2paRUhqRVZEY3hDNDl5NVlUdFFB?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical Technology opens nationwide burn-pit data registry", "summary": "", "url": "https://finance.yahoo.com/m/0455d054-b6ad-3295-ac60-d9f0da8224cf/creative-medical-technology.html", "source_name": "Proactive", "published_at": "2026-06-16T19:49:00+00:00", "published_display": "16 Jun 2026 19:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical Technology Holdings, Inc. Advances Project PHOENIX into Nationwide AI Driven Virtual Data Collection Phase for U.S. Veterans Exposed to Burn Pits and Toxic Hazards", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/creative-medical-technology-holdings-inc-130000192.html", "source_name": "GlobeNewswire", "published_at": "2026-06-16T13:00:00+00:00", "published_display": "16 Jun 2026 13:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical Technology (CELZ) Slips 4.6% as Stock Approaches Key Support - Algorithmic Stock Picks", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPS0I0LXc2OTdnYWI5UjhIdGhocXUySGdES184R0R3MUQ1V05WenRJeExXeElMdzMyaDZwUlRxSGVYRkJfN3AzZElQcnVjWDg1Yl8tOU1PWnBwX2ZVTkNrWlp3STE5YzNKQlVsQldOTWZhb0duYnV1SVVUMEtpeS1GNTRXLTJRWFJVRTQ0UzBydGNNaDU1aHRGMXlfdnlERE1DVjdYZDRHM0o0eUdCalZjRl84TUswaEptQXE1UQ?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical Technology (CELZ) Edges Lower by 0.22% as Stock Consolidates Between Key Levels - Calendar Spread Trade", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxPeDhqdHYzaVQzY2YzS21LazZlNXUtSlVDbHRyOGwzWkpDelNlVWh4Ym9sREtDX1RVRFVNVTNVQkMwd2hsTXljdnVNSWVqaUMycGJPUkY1UUR4bGVLaWlWeEpHVHNIdnMzcWJZYUg4RnlBbGFxSWNfNGJ3MTV0LU1XbGdXaGY0ZFF4R0Q3c2FXWHdiWEI0QUs1aTltdVdVRkwwUndVLTNQTE92d1pVaHZNSENfN3pCQlF3dXRtN04tX3dQRm5OYmFkRlpuSExyWjI3bmc?oc=5", "source_name": "dars.gov.et", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical Technology Holdings (CELZ) Slips 1.3% as Stock Tests Key Support at $2.17 - Gap Up Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxNMTRVeHQ1STJWa0FqRDN1aTFwT0I5QzlwSGViS0pHTTJZY0lsbjFYT01RTFlJanhqUnM4SFowbExic0oySWs2NWYzY01YVmFVZXZhSTlmZ1JVay1YQ280WEE2dUZuZEtVbnJGVUZqUDNPWG1EUXl2SGxVTkh1OGQtRktGaVJMQlNxX3Vud1ktS0RSYW9kaFpTU0ZOR2FzT1QzSk82MHNBanNJSDJZQVVzWXQtX1lSOE01RS1NRU40VmJzOWc0NVQxSk1KOG4?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Creative Medical Technology Holdings, Inc. Reports Breakthrough 93% Response Rate in Ultrasome\u2122 Knee Osteoarthritis Program, Expanding CELZ-201 Platform into Scalable Cell-Free Regenerative Therapies", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/creative-medical-technology-holdings-inc-130100026.html", "source_name": "GlobeNewswire", "published_at": "2026-04-28T13:01:00+00:00", "published_display": "28 Apr 2026 13:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Expect Breakeven For Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Before Long", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQTElwYTlpVVFTRVhmUkpxZDh0RUdUcUd3RnJwOEx3c0MtUml1ZkVSdktpcktqaFdja1pNS0RaaWxLaUtzVmw4RFJaUGdsaHJZWWQtWFNpTFREVThjcDB4NUdGUVV0WjlxcjVlSUE0YkNOSHFZNnRJUjBFOGZlb1d3Z3Brb1MzdXlmaFU5T19oTTZLZEN0WlB3dTF1YXJqSVJNNmc1NGtwcWx3cWJaQ19SYw?oc=5", "source_name": "Market source", "published_at": "2026-04-09T07:00:00+00:00", "published_display": "09 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Day 6 of Gains Streak for Creative Medical Technology Stock with 43% Return (vs. 123% YTD) [10/27/2025]", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-wFBVV95cUxQMFlhZTg3aHZ0eXo5RXl5VmdxVElabFBHWHRuRENpdzNteFRDcVlYTEpvUjl1cWZSRXdpMFA3VnJlUTZSc2xfU29LVktsNEVhUVQ3WG9IVktiak9tQ0ZwazFnQ2NzNS1BS1FVQzg3NGhSbFNWbzVpcnRLVFpSS09GZ01CNng1eHR0blBleElmbFU5bmNxWEdBZmdMSGRvZ1FzOTk3VTE4b2tKYXBXbmNIZDBxYVhOa0NwMDNEREEyM2sya0JsVzE4WjVkSUoxNnpzSXlyX2cwRVdDMS1DMW9MMkNkTml5WHRtem9qQVlLYXAzcC14eWVWYVdRRQ?oc=5", "source_name": "Trefis", "published_at": "2025-10-27T07:00:00+00:00", "published_display": "27 Oct 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should I buy Creative Medical Technology Holdings, Inc. (CELZ)", "summary": "", "url": "https://news.google.com/rss/articles/CBMibEFVX3lxTE8tTGRCLVAyTUtsVGgwc3c0RjNoWnpLU3BDcnJVZjZ2bm5UVFhYT0dkdEllaG5QM1YyVnpEeU1DbzZjWWZHbXlUaTNyUXlvU0NoY3lqREhPS2xZMkxCTmFGVHFTLTV1bGNtdDVtMA?oc=5", "source_name": "Zacks Investment Research", "published_at": "2025-07-31T07:00:00+00:00", "published_display": "31 Jul 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What is the current Price Target and Forecast for Creative Medical Technology Holdings, Inc. (CELZ)", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTE9NQnRQVVl2Q0loeGY5NVY0cXF6bTI2emdBNVAwMTV0bUE0eEpUbk94MW5ZSFRyY01TVzFSODlNWFVrYW1xUE56cUFVOFRESDA3clJGaU1RMTRBaTBkMWNqcXVaQmdiekE4VWRCMzBDR1ZieGhGYkRfSg?oc=5", "source_name": "Zacks Investment Research", "published_at": "2022-07-29T00:34:36+00:00", "published_display": "29 Jul 2022 00:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CELZ Stock Price and Chart \u2014 NASDAQ:CELZ", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE9RSFotU1ROSjY4Z2hTdW9UUmNHeXJfOUN3V0ZYeThjVHV3RzQtVGxEbWpLWHBURmNVYzY3ZnRTM25Ud3REdjc3QUFJUVJ6QW9VVnhyZjhLX2lyb0Fh?oc=5", "source_name": "TradingView", "published_at": "2022-03-24T07:00:00+00:00", "published_display": "24 Mar 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxQcjZqdzdBcURDdWxCZUtoU1dTaHYtVUFRdlo1a3ZGZGY3a1dBX2x2UVE3Y1hoX1duLXhGU2p0UXU2eTctNng5eFJ5c1M0bHBNQ0VmZTFZanhYU21yTVo0UTQtVENveVV1aWdpc3luUlgza3AyUEI2OGx4aEhXc0pBTHpWUThSYXI1S3RTS21lQ21vWjd6MGY4ZDRwVWlEakc3SmFKN09aM0Rlb2pFT3BNNW1GTExnSElFb2NqR3JhX0J3MlptQy1mMk9IOTZtdS1HU25fLU9aOU9XZi1PRDlkZVI2cnhackHSAewBQVVfeXFMTlc2N3pIUkxDd1NtTlVRMEdac1JNSDF3cUNidkZrTElQREZaUTZjZmFHdUVWYW8wcDg1LThGbnlPb0VQUFI4ZXdjSXR6Ym5DREM1X2lyQUtYTzF3XzBBTGRGcEZQQ3FjLWxCQ0locVM2dGZJR1kxYmlBQXdsbFhfbFFISS1wSUkxQmp4U2d2Z3JHbXRPMUpnajBydTRmNnQzZmF5eEdzOVFRNUdDNVV0aDJQNERCaXN3ZGo1UUc1ZGkwOFYzcDgxS1ltZllDeTFxNFIxT3FyOUxLMFNrLUhtOFNFV0xMYkM5TlpWMzk?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 93, "total_relevant": 50, "sentiment_summary": {"positive": 11, "negative": 9, "neutral": 30, "score": 53, "total": 50, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 85, "events": [{"event": "general", "label": "Market update", "weight": 19.05, "count": 34}, {"event": "earnings", "label": "Earnings", "weight": 4.4, "count": 10}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 1.65, "count": 3}, {"event": "analyst", "label": "Analyst action", "weight": 1.1, "count": 2}, {"event": "guidance", "label": "Guidance", "weight": 0.9, "count": 1}], "positive_events": 11, "negative_events": 9}, "market_context": {"has_market_context": true, "latest_close": 0.91, "latest_week": "2026-07-10", "one_week_move": -24.6, "four_week_move": -58.0, "twelve_week_move": -63.1, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.464083, "market_dynamics_buy_signal": false, "relative_strength": -68.840149, "fair_value_gap": -72.8, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 46.8169, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-24.6% over one week, -58.0% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 63, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 9}, {"label": "TradingView", "count": 9}, {"label": "Market source", "count": 6}, {"label": "GlobeNewswire", "count": 3}, {"label": "Medical Buyer", "count": 2}, {"label": "StocksToTrade", "count": 2}, {"label": "The Manila Times", "count": 2}, {"label": "Benzinga", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 42}, {"label": "Industry context", "count": 8}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 34}, {"label": "Earnings", "count": 10}, {"label": "Regulatory and legal", "count": 3}, {"label": "Analyst action", "count": 2}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "85/100 classification confidence."}, {"label": "Company focus", "value": "42", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-24.6% over one week, -58.0% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Negative", "tone": "negative", "text": "Creative Medical Technology (CELZ) plans big share boost and warrant approval"}], "updated_at": "2026-07-16T00:50:46.694399+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}